Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)

​ Conditions: Triple-Negative Breast Cancer (TNBC); Neoadjuvant Chemotherapy; Chemotherapy Effects

Interventions: Drug: nab-paclitaxel, carboplatin, and bemotuzumab; Drug: epirubicin, cyclophosphamide, and bemotuzumab

Sponsors: Zhejiang Provincial People’s Hospital

Not yet recruiting Conditions: Triple-Negative Breast Cancer (TNBC); Neoadjuvant Chemotherapy; Chemotherapy Effects
Interventions: Drug: nab-paclitaxel, carboplatin, and bemotuzumab; Drug: epirubicin, cyclophosphamide, and bemotuzumab
Sponsors: Zhejiang Provincial People’s Hospital
Not yet recruiting